The 2021 China Development High-Level Forum will be held at the Diaoyutai State Guest House in Beijing from March 20 to 22Online and offlineHeld simultaneously.RocheGroup CEO Shi Wan attended and delivered a speech.

According to Shi Wan, Roche Group is a leading biomedical company, headquartered in Switzerland, with business development in more than 100 countries and regions. “We entered the Chinese market 90 years ago, so we have been doing business in China for a long time. We are the first biomedical company in China, and have established a very complete R&D value chain and manufacturing value chain in China.”

Shi Wan also said that the Roche Group has always cooperated with Chinese healthcare companies, and is also very grateful to the Chinese government for its commitment to continuing openness and encouraging international cooperation.

Referring to industry development, he emphasized the importance of health data. “In fact, the COVID-19 response has clearly shown China's leading position in terms of digital value. Let's imagine that if all COVID-19 treatments and data obtained during the process can be stored and analyzed in a systematic manner, there is no doubt that we can better control the epidemic and control the epidemic faster.”

He believes that domestic and foreign companies in all regions should be guaranteed equal treatment in terms of health data, in addition to having good relevant governance institutions. “This may not be the case now in terms of health data, especially genetic data. This data is critical to modern research and critical to the development of the life sciences industry.”

Sina's statement: All conference transcripts are compiled from live shorthand. Without review by the speakers, Sina posted this article for the purpose of conveying more information, which does not mean that it endorses its views or confirms its descriptions.

Responsible editor: Liang Bin SF055